QSAR Studies of 3-(4-(3-(Substitutedphenyl) Acryloyl) Phenyl)-2-Substituted phenyl/Phenylthiazolidin-4-ones for Anticancer Activity

Abstract

Abstract

Both, Chalcone and 4-thiazolidinone, are therapeutically significant organic moieties with anticancer activities. QSAR (Quantitative structure–activity relationship) studies of ten synthesized chalcone-thiazolidinone hybrids have been described for anticancer activity against three cancer cell lines: A-549 (Human lung adenocarcinoma), U-87 MG (Human glioblastoma cancer cells) and COLO-205 (Human colon cancer cells). The developed linear QSAR models have significant statistical quality showing good fitting ability and robustness. The Q² and R² values of all the described models were more than 0.5 which corroborated the internal predictive ability of the resultant QSAR equations. Wlambda3.mass, SC-3, FNSA-3, BCUTp-1l, Wlambda1.unity descriptors were imperative in elucidation of anticancer activity trends.

Keywords: Chalcone-thiazolidinone hybrids, anticancer activity, cell lines, QSAR

Cite this Article

Ashwani Kumar, Ruchika Goyal, Sunil Kumar et al. Qsar Studies of 3-(4-(3-(Substitutedphenyl) Acryloyl) Phenyl)-2-Substituted Phenyl/Phenylthiazolidin-4-Ones for Anticancer Activity. Research & Reviews: A Journal of Drug Design & Discovery. 2016; 3(3): 16–22p.